- BiondVax Pharmaceuticals Ltd. (BVXV): Important & Key Factors of Healthcare Stock
- What's the Analyst Recommendation for iHeartMedia Inc. (IHRT)?
- Let’s Take a Look at Milestone Pharmaceuticals Inc. (MIST) Stock
- Is it Time to Sell/Buy United States Steel Corporation (X) Stock After Recent Trade?
- Aptose Biosciences Inc. (APTO) is down -10.05% this year
Goldman announced it was Upgrade coverage of JPMorgan Chase & Co. in a research note on July 24, 2020. The analysts assigned a Buy rating to the stock. Atlantic Equities rated the stock as an Overweight in a research noted published on July 22, 2020. Wolfe Research rated the stock as an Outperform in a research note published on July 09, 2020.
BURKE STEPHEN B, the Director of JPMorgan Chase & Co., bought 75000.0 shares at the valuation of $87.99 during an exchange that occurred on Apr 16, which implies that BURKE STEPHEN B is holding 75,000 shares at the estimation of $6,598,958 dependent on the most recent closing price.
In another transaction, on Apr 15, Chief Risk Officer of JPMorgan Chase & Co., BACON ASHLEY, sold 13027.0 shares at the price of $91.12. After this activity, BACON ASHLEY now keeps 137,243 shares of JPMorgan Chase & Co., esteemed at $1,187,081 with the most recent shutting price.
JPM Recent Trade
The share price of JPM descended by -$2.66 during the exchanging session on 07/30/20 to exchange at $97.02. JPMorgan Chase & Co. stock has an exchanging volume of 14.73 million shares, which is low, contrasted with its 3-months average volume of 23.12M shares. Its market capitalization has now reached to $297.73B and analysts have a consensus target price of $113.88 in the 12-month period.
JPM Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, JPM price has dropped by -1.98%. In the course of past three months sees the stock go up around 1.32%, while it has lost -28.60% over the past six months and -30.40% since the start of the year.
JPM Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 16.11 billion, which was lesser than the gauge of 27.48B made by certain experts. For that equivalent quarter, JPMorgan Chase & Co. posted $1.38 earnings per share (EPS) which was above the consensus estimate of $1.04 by $0.34, which represents to an expansion by 32.70%.
JPM Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on JPMorgan Chase & Co. has seen its stock exchanging -16.20% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +17.74% above its three-month low. A more extensive look sees JPM exchanging -31.24% beneath its 52-week high and 26.15% above from its 52-week low price.
JPM Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 1.88%, while it has a month to month instability of 2.48%. Ticker has an ATR (Average True Range) of 2.65 and a beta factor of 1.17.